Kimberly-Clark stated its chief monetary officer, Nelson Urdaneta, will develop into the finance chief of the mixed firm it is going to create after finishing its $40-billion acquisition of Tylenol-maker Kenvue.
The deal, introduced in November, is anticipated to shut within the second half of 2026, pending regulatory approvals.
The brand new entity will function with 4 enterprise segments: North America, Asia Pacific Focus Markets, Europe-Center East-Africa (EMEA), and Enterprise Markets, every led by regional presidents.
Russ Torres will function group president and chief working officer, whereas different senior roles embrace chief development officer, chief R&D officer and chief provide chain officer.
Kimberly-Clark Kenvue Deal
Kimberly-Clark stated greater than 30 groups engaged on the mixing have recognized alternatives to develop the enterprise and scale back prices.
The acquisition of the previous Johnson & Johnson unit, Kimberly-Clark’s largest-ever deal, is about to create a worldwide well being and wellness big with annual gross sales of roughly $32 billion, increasing the corporate’s attain in client well being and private care.
Upon closing, Kimberly-Clark’s CEO, Mike Hsu, is about to take over as the highest boss and chairman of the mixed firm, it had stated on the time of the deal.
In January, the corporate exceeded quarterly revenue expectations, helped by value controls and regular demand for its merchandise together with Huggies diapers and Kleenex tissues.
Costs declined 1.1% whereas natural gross sales rose 2.1% within the fourth quarter, pushed by a 2.7% development in general volumes as customers stocked up on important merchandise comparable to floor cleansing brokers, disinfectants and paper napkins at warehouse-style membership shops that promote bigger, worth packs.
